Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR01N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,405
Award facts
- Contract value 100% obligated
- $19,404.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,404.59 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on December 5, 2025, with an ultimate completion date of December 8, 2025. The contract utilizes firm fixed price pricing under a non-set-aside, competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which functions as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency and other government healthcare systems.
Dupixent (dupilumab) is a prescription biologic medication primarily used to treat moderate-to-severe atopic dermatitis, eczema, and other inflammatory conditions. The supply of this specialized pharmaceutical through the DLA's medical supply chain supports the healthcare needs of active duty service members, retirees, and beneficiaries across the military healthcare system. AmerisourceBergen's role as a prime pharmaceutical vendor reflects its demonstrated capability to meet federal procurement requirements for specialized medications and medical supplies, positioning the company as a key logistics partner in ensuring consistent availability of critical therapeutic agents throughout the military health system.
Quick answers
Who was awarded contract SPE2DR26FR01N?
SPE2DR26FR01N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FR01N worth?
The government has obligated $19,405 on SPE2DR26FR01N.
Is contract SPE2DR26FR01N an order under another contract?
Yes. SPE2DR26FR01N is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR01N competed?
The extent of competition for SPE2DR26FR01N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award